Imaging response assessment with post 177Lu-PSMA-617 therapy SPECT-CT in metastatic castrate resistant prostate cancer: Adding value with a technologist driven postprocessing workflow

被引：0
|
作者：
Messmer, Jaylee [1 ]
Soehl, Kaleb [2 ]
Burkett, Brian [3 ]
Kendi, Ayse [3 ]
Johnson, Geoffrey [3 ]
Childs, Daniel [3 ]
Abdelrazek, Ahmad [3 ]
Mahmoud, Ahmed [3 ]
Pessoa, Rodrigo Rodrigues [3 ]
Nabavizadeh, Reza [3 ]
Kwon, Eugene [3 ]
Matthew, Patrick Navin [3 ]
Thorpe, Matthew [3 ]
机构：
[1] Mayo Clin, Sch Hlth Sci, Rochester, MN USA
[2] Mayo Clin, Nucl Med Technol Program Minnesota, Rochester, MN USA
[3] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
TS16
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617
    Ferdinandus, Justin
    Eppard, Elisabeth
    Gaertner, Florian C.
    Kuerpig, Stefan
    Fimmers, Rolf
    Yordanova, Anna
    Hauser, Stefan
    Feldmann, Georg
    Essler, Markus
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (02) : 312 - 319
  • [2] Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Ferdinandus, Justin
    Eppard, Elisabeth
    Kuerpig, Stefan
    Gaertner, Florian
    Fimmers, Rolf
    Hauser, Stefan
    Essler, Markus
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [3] Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Ferdinandus, J.
    Eppard, E.
    Kuerpig, S.
    Gaertner, F.
    Fimmers, R.
    Yordanova, A.
    Hauser, S.
    Essler, M.
    Feldmann, G.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S212 - S213
  • [4] Salivary gland dosimetry in therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Happel, C.
    Voeller, L.
    Kranert, W. T.
    Baumgarten, J.
    Groener, D.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S102 - S102
  • [5] Hematotoxicity after radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Zimbelmann, Stefanie
    Eppard, Elisabeth
    Hauser, Stefan
    Kuerpig, Stefan
    Yordanova, Anna
    Essler, Markus
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [6] SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617
    Demirci, Ridvan Arda
    Gulati, Roman
    Hawley, Jessica E.
    Yezefski, Todd
    Haffner, Michael C.
    Cheng, Heather H.
    Montgomery, Robert B.
    Schweizer, Michael T.
    Yu, Evan Y.
    Nelson, Peter S.
    Chen, Delphine L.
    Iravani, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) : 1945 - 1951
  • [7] EVALUATION OF RESPONSE TO 177LU-PSMA-617 BY SITE SPECIFIC DISEASE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
    Mohamed, E. Ahmed
    Giuseppe, Reitano
    Ahmed, Mahmoud
    Umar, Ghaffar
    Tuba, Kendi Ayse
    Jeffrey, Karnes R.
    Eugene, Kwon
    Jack, Andrews
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [8] EVALUATION OF RESPONSE TO 177LU-PSMA-617 BY SITE SPECIFIC DISEASE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
    Mahmoud, Ahmed M.
    Ahmed, Mohamed E.
    Abdelrazek, Ahmad
    Childs, Daniel
    Kendi, Ayse T.
    Johnson, Geoffrey
    Karnes, Jeffrey
    Kwon, Eugene
    Andrews, Jack
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1004 - E1004
  • [9] Value of Post-Therapy Quantitative SPECT for Monitoring Response to 177Lu-PSMA-617 Therapy
    Meyer, Catherine
    Yilmaz, Burcak
    Szidonya, Laszlo
    Winters, Celeste
    Mench, Anna
    Mallak, Nadine
    Mittra, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [10] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
12345